categoryMenu_new
 
  Home
  EXTRAORDINARY AH Teaching from Spiritual Hierarchy
  AbundantHope
  NEW READERS! Read Here First
  Supporting AH
  Leadership of AbundantHope
  Announcements
  Regional AH Sites
  Other Sites with AH material
  Contact Us
  Becoming A Messiah
  OUR PUBLIC FORUM IS OPEN TOO ALL
  Mission Ideas
  System Busting
  Cleric Letter/English
  Translations of Cleric Letter
  AH Member Writings
  Candace
  Ron
  Rosie
  Jess
  Brian's Poetry
  James
  Giuseppe
  Esteban
  Telepathic Messages
  Candace
  Jess Anthony
  Vince
  Leonette
  John
  Adam
  Bela
  Joyce
  Hazel
  Kibo
  Peter
  Rosie
  Johan
  Lucia
  Lucia G
  Rubens
  Shellee-Kim
  Ben
  Dorothea
  Solon
  Others
  Targeted Messages
  Hano
  Light Flower
  Changing The Face Of Religion
  - Phoenix Journals - PDF in German
  Candace on Religion
  Other Spiritual Pieces
  Spiritual Nuggets by the Masters
  Phoenix Journals
  Phoenix Journals - PDF
  Telepathic Messages PDF books
  Selections from the Urantia Book
  Illustrations For The Urantia Book
  CMGSN Pieces
  THE WAVE
 
  Environment/Science
  David Crayford and the ITC
  Health and Nutrition
  Podcasts, Radio Shows, Video by AH
  Political Information
  True US History
  Human/Animal Rights
  The Miracle That Is Me
  Education
  Resources
  911 Material
  Books - eBooks
  government email/phone #'s
  Self Reliance
  Video
  Websites
  Alternative News Sources
  Art and Music
  Foreign Sites
  Health and Healing
  Human/Animal Rights
  Scientific
  Spiritual
  Vegan Recipes
  Translated Material
  Dutch
  Gekanaliseerde berichten Jess
  Gekanaliseerde berichten Candace
  Gekanaliseerde berichten Anderen
  Artikelen/berichten
  French
  Canal Jess
  Par Candace
  Other Channels
  Articles
  German
  Telepathische Nachrichten (Candace)
  Telepathische Nachrichten (Jess)
  Telepathische Nachrichten (div.)
  AH Mitgliederbeiträge (Candace)
  AH Mitgliederbeiträge (Jess)
  Spirituelle Schätze
  Italian
  Translations - Candace
  Translations - Jess
  Translations - Others
  Portuguese
  by Candace
  By Jess
  By Others
  Spanish
  Anfitriones Divinos
  Bitácoras Fénix
  Creadores-de-Alas (WingMakers/Lyricus)
  Escritos de Candace
  Escritos de Otros
  Monjoronsón
  Telemensajes de Candace
  Telemensajes de Jess Anthony
  Telemensajes de Otros
  Chinese
  By Candace
  By Jess
  By Others
  Korean Translations
  Hungarian Translations
  Swedish Translations

Search
[an error occurred while processing this directive]
Environment/Science Last Updated: May 27, 2020 - 7:27:41 AM


CROOKS: Two Moderna Executives Sold $30 million of stock before Truth About Vaccine Trial Failure was Uncovered
By Joaquin Flores
May 27, 2020 - 4:33:17 AM

Email this article
 Printer friendly page Share/Bookmark

https://www.sott.net/article/435166-CROOKS-Two-Moderna-executives-sold-30-million-of-stock-before-truth-about-vaccine-trial-failure-was-uncovered


Joaquin Flores
Fort Russ
Tue, 26 May 2020
18:09 UTCLorence Kim  Tal Zaks Moderna

Two executives at drug firm Moderna quietly sold nearly $30 million of stock when they unveiled a coronavirus vaccine and value surged, before the share price quickly fell again amid skepticism from the medical community.

Moderna's chief financial officer Lorence Kim and chief medical officer Tal Zaks dumped the staggering value of stocks on Monday and Tuesday when the share price skyrocketed following the company's announcement of what it described as 'positive' results from its vaccine trial.

The two executives pocketed almost $25 million in profits in a day's work before experts cast doubt on the vaccine's success and sent shares tumbling. FRN reported on the false reports, citing an article written by Robert F. Kennedy Jr. that the Moderna vaccine results were a failure.

Fake fact checkers working for social media firms tagged FRN's report as 'false information', insisting instead that the Moderna tests had been a success. Investors in biotech and pharma, and the virologists they depend on, apparently agreed with FRN's assessment.

Indeed, Kim exercised 241,000 options for $3 million Monday, then instantly sold them for $19.8 million, taking a tidy profit of $16.8 million, SEC filings seen by CNN Business show. On Tuesday, Zaks exercised $1.5 million stock options before making a profit of $8.2 million when he immediately offloaded them for $9.77 million.

ModernaStocks in Moderna surged as much as 30 percent Monday to $87 a share, after it released what it falsely claimed as 'promising results' of its COVID-19 vaccine trial.

Moderna's chief financial officer Lorence Kim and chief medical officer Tal Zaks dumped the staggering value of stocks on Monday and Tuesday when the share price skyrocketed following the company's announcement over its vaccine trial. The biotech company released results from its COVID-19 vaccine trial Monday, after it became the first US company to start a clinical trial for a vaccine back in March. This sparked hope that a vaccine for the deadly virus could make it to market by January and sent Wall Street investors into overdrive.

Stocks in Moderna surged as much as 30 percent Monday to $87 a share, and the company's market value climbed to $29 billion. While investors raced to get a slice of the firm, the two insiders CFO Kim and CMO Zaks dumped the near-$30 million of shares between them on Monday and Tuesday.

According to filings, Kim also offloaded stocks in the days before the results of the trial were announced, selling 20,000 shares worth $1.3 million on May 15. The timing of the sales appear suspicious, but Moderna insisted this week's sales from the two insiders were executed under automated insider trading plans, known as 10b5-1 plans. Such plans lay out future stock trades at set prices or on set dates, with transactions typically being carried out without the insiders taking any action. 'These transactions are executing automatically pursuant to these trading plans,' the company said.

Experts have said this means the deals are perfectly legal. Andrew Gordon, director of research services at Equilar, told CNN Business the executives' actions would only pose a 'legal issue if they created or modified their 10b5-1 plan while in possession of material insider information. 'It's not uncommon for insiders to sell shares they own, nor is it bad for them to capitalize on the current stock price.'

The company's share price wavered more as the week went on as the medical community gave a mixed response to the success of the vaccine trials. Dr Fauci called the trials 'optimistic'. Health website Stat cast doubt on the vaccine Tuesday, saying not enough information was available to understand if the phase one trial was a success and sending shares down to $71.67 that day. Shares fell further to a low of $67.05 Thursday, down 16 percent from its Monday close.

Other experts have also voiced their skepticism over the trials. Peter Hotez, a vaccine scientist at Baylor College of Medicine in Houston, Texas, told Nature.com he was 'not convinced' by Moderna's claims. 'I'm not convinced that this is really a positive result,' Hotez said. Shares then went up again Friday to $68.60 after Dr Anthony Fauci, the federal government's top immunologist, said he was 'cautiously optimistic' about Moderna's vaccine. 'Although the numbers were limited, it was quite good news because it reached and went over an important hurdle in the development of vaccines. That's the reason why I'm cautiously optimistic about it,' Fauci said at a CNN town hall on Thursday.

The National Institute of Allergy and Infectious Diseases, which Fauci is head of, is developing the vaccine in collaboration with Moderna. Dr. Carlos del Rio, an Emory University professor of medicine which is testing Moderna's vaccine, echoed Fauci's optimism in an interview with CNBC Friday. 'I am cautiously optimistic. We are developing at a pace that has never been done before,' he said.

Moderna's phase one study of 45 participants and measuring the antibodies in eight participants found all eight had developed antibodies to the virus at levels at or above the antibodies found in people who have recovered from COVID-19. 'Trying to think that, a year after a virus has been identified, we will have a vaccine ready to deploy and ready to go into massive distribution, it's simply mind-boggling to me. 'I have to be a little cautious and say I hope it happens, but I don't want to be - I want to make sure we do it the right way.'

It expects to enter phase two trials with 600 participants soon and phase three trials in July.

[Colour fonts and bolding added.].




All writings by members of AbundantHope are copyrighted by
©2005-2020 AbundantHope - All rights reserved

Detailed explanation of AbundantHope's Copyrights are found here


Top of Page

Environment/Science
Latest Headlines
THE STORY OF INFLUENZA. AN IMPORTANT TALE TO TELL YOUR FRIENDS.
How Technology is Disrupting Leading Industries
“No One Has Died From The Coronavirus”
Black Entrepreneur Develops Hemp Farming Co-Op to End Systemic Racism in American Agriculture
The Science of Plant Intelligence Takes Root
Ancient Engineering Wonders: This 1,200-Year-Old Temple Was Carved out of Solid Rock
Transhumanism: The New Religion Of The Coming Technocracy
Incredible Rainbow Iridescent Clouds Photographed Over Hanoi
New Film Features Top Scientists Revealing Cell Phone Radiation Risks and Industry Methods Keeping Us Clueless
U.N. Warns of Devastating Environmental Side Effects of Electric Car Boom
Mea Culpa: Another Leading Environmentalist Admits He Got It Wrong over Climate Change, but MSM tries to CENSOR him
Epic 10-Year Time-Lapse Video of the Sun Is a High-Definition Audiovisual Masterpiece
Bayer/Monsanto Settlement Cheats Roundup Victims
A Winning Trifecta for Climate Science and Rationality
‘Godzilla Dust Cloud’ from Sahara Slams the US, Southern Cities Face Hazardous Air Quality
Covid-19 Was In Spanish Sewage As Early As MARCH 2019, study claims
COVID-19 and Roundup: An Immuno-Comprised Marriage from Hell
The Evil Revealed In First US Nuclear Test: 74 Years Ago Over Bikini
Really Bizarre Things Are Happening All Over The Globe
Bayer Pays Out $15.9b to Settle Roundup Cancer Claims